A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid Malignancies

Clinical trial NCT07613723 · RECRUITING

Trial details

NCT number: NCT07613723
Sponsor: Zelluna Immunotherapy AS
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer Squamous Non-Small Cell Lung Cancer (NSCLC)Synovial Sarcomas Head and Neck Cancer

Start date: 2026-05-01
Primary completion: 2028-12-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.